8:32 am Merck announces the Biologics License Application for V503, its investigational 9-valent human papillomavirus vaccine, has been accepted for standard review by the FDA
View todays social media effects on MRK
View the latest stocks trending across Twitter. Click to view dashboard
See who Merck is hiring next, click here to view
